In Situ Multimodality Imaging of Cancerous Cells Based on a Selective Performance of Fe2+-Adsorbed Zeolitic Imidazolate Framework-8

  • Tianyu Du
  • , Chunqiu Zhao
  • , Fawad ur Rehman
  • , Lanmei Lai
  • , Xiaoqi Li
  • , Yi Sun
  • , Shouhua Luo
  • , Hui Jiang
  • , Ning Gu
  • , Matthias Selke
  • , Xuemei Wang

Research output: Contribution to journalArticlepeer-review

57 Citations (Scopus)

Abstract

Metal-organic frameworks possess tremendous potential in biomedical areas for their particular structure. In this study, the authors explored Fe2+-adsorbed nanoscaled zeolitic imidazolate framework-8 (ZIF-8) for in vivo multimodal imaging of cancerous cells for early diagnosis of target cancers. The observations demonstrate that adding Fe2+ into the suspension of ZIF-8 can neutralize the alkalinity and lower toxicity, while the Fe2+-adsorbed ZIF-8 can readily transform to fluorescence ZnO and super paramagnetic Fe3O4 under the synergistic reaction of ROS, GSH, and acids. It is evident that the formation of the nanoclusters ZnO and Fe3O4 only occurred in cancerous cells and does not take place in normal cells, which can be attributed to the different ROS levels and specific micro-environment in tumor and normal cells. This raises the possibility for the Fe2+-adsorbed zeolitic imidazolate frameworks to act as promising agents for the in vivo multimodal imaging of cancers in their early stage.

Original languageEnglish (UK)
Article number1603926
JournalAdvanced Functional Materials
Volume27
Issue number5
DOIs
Publication statusPublished - 3 Feb 2017
Externally publishedYes

Keywords

  • cancer diagnosis
  • in situ biosynthesis
  • in vivo multimodality imaging
  • zeolitic imidazolate framework-8

Fingerprint

Dive into the research topics of 'In Situ Multimodality Imaging of Cancerous Cells Based on a Selective Performance of Fe2+-Adsorbed Zeolitic Imidazolate Framework-8'. Together they form a unique fingerprint.

Cite this